Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Mavilio

Showing results (101-110 of 103) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 103 results.
Human Gene Therapy|July 31, 1999
Reversible immortalization of human myogenic cells by site-specific excision of a retrovirally transferred oncogeneL Berghella, L De Angelis, M Coletta, et al.
The Journal of Clinical Investigation|May 29, 1998
High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathiesL Lattanzi, G Salvatori, M Coletta, et al.
Nature Medicine|April 2, 2003
Safety of retroviral gene marking with a truncated NGF receptorC Bonini, M Grez, C Traversari, et al.
Pageof 11

Showing results (101-110 of 103) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 103 results.
Human Gene Therapy|July 31, 1999
Reversible immortalization of human myogenic cells by site-specific excision of a retrovirally transferred oncogeneL Berghella, L De Angelis, M Coletta, et al.
The Journal of Clinical Investigation|May 29, 1998
High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathiesL Lattanzi, G Salvatori, M Coletta, et al.
Nature Medicine|April 2, 2003
Safety of retroviral gene marking with a truncated NGF receptorC Bonini, M Grez, C Traversari, et al.
Pageof 11